Vincogen Corporation

Development of biochip and T4 phage display platforms

Vincogen Corporation was established in 2000 and has developed a proprietary radio-frequency (RF) biochip platform and T4 Phage Display platforms.

Derhsing Lai, Ph.D (Founder and President/CEO)
Frank Hsiung, M.S. (Partner; VP of Technology)
Zhao Jun (James) Ren, Ph.D (Director of Bio-Expression)
Mototaka Senda, Ph.D. (Vincogen, Japan)
Wim Shih (Business Development)

Andre Tartar, Ph.D.
Mototaka Senda, Ph.D
Steve Lee, M.S.
Yasuhide Hibino, Ph.D.
Say-Fone Phounsavan, MD, Ph.D., D.Sc.(Pan Nien Chung)

675 US Highway One
North Brunswick, NJ 08902
USA
Phone: +1-732-2478972
Fax: +1-732-2476742

ICBiochip is an integrated circuit microchip that differs from current biochips and can be applied across the life sciences. This chip is between 1 millimeter and 200 micrometers in size and consists of a radio frequency identification system,a metal option that uniquely identifies the chip, a transponder to which biological molecules are fixed with a phage or peptide display system and an electrode to use electrochemical luminescence wireless. The chip then responds by inducing bonded molecules to emit electrochemical luminescence.